Non-injectable versus injectable epinephrine treatment thresholds for acute allergic reactions in the community

Post time Half hour(s) ago

journal：The Journal of Allergy and Clinical Immunology: In Practice

Authors：Timothy E. Dribin; Hugh A. Sampson; David Schnadower; Aikaterini Anagnostou; Adam T. Fox; David B.K. Golden; Kenneth A. Michelson; Marcus S. Shaker; Julie Wang; Waleed Alqurashi; Amal H. Assa’ad; David C. Brousseau; Dianne E. Campbell; Ronna L. Campbell; Thomas B. Casale; Derek K. Chu; Ashley Lynn Devonshire; Motohiro Ebisawa; Matthew Greenhawt; David M. Lang; Jay A. Liebermann; Stephanie Leonard; Douglas P. Mack; Antonella Muraro; Mark I. Neuman; Kimberly A. Risma; Graham Roberts; Nicholas Sargant; Scott H. Sicherer; Jonathan M. Spergel; Dana Wallace; Susan Waserman; Margitta Worm; Vincetta Kahmann; Brad Sobolewski; Yin Zhang; Stephanie Boyd; Nanhua Zhang; Sanaz Eftekhari; Hannah Jaffee; Melanie Carver; Carlos A. Camargo

Published date：2026-4-

DOI：10.1016/j.jaip.2025.12.022

PDF link：https://www.sciencedirect.com/sc ... 213219825012243/pdf

Article link：https://doi.org/10.1016/j.jaip.2025.12.022

Article Source：Elsevier BV。

Remark：

[Elsevier] Non-injectable versus injectable epinephrine treatment thresholds for acute allergic reactions in the community

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Non-injectable versus injectable epinephrine treatment thresholds for acute allergic reactions in the community Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Non-injectable versus injectable epinephrine treatment thresholds for acute allergic reactions in the community